本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ADMA Biologics Inc

8.61
-0.5300-5.80%
盤前8.730.1214+1.41%08:58 EDT
成交量:358.92萬
成交額:3,118.83萬
市值:19.29億
市盈率:12.29
高:9.13
開:9.08
低:8.55
收:9.14
52周最高:20.46
52周最低:7.21
股本:2.24億
流通股本:2.11億
量比:1.43
換手率:1.71%
股息:- -
股息率:- -
每股收益(TTM):0.7004
每股收益(LYR):0.6000
淨資產收益率:41.90%
總資產收益率:21.78%
市淨率:4.72
市盈率(LYR):14.35

資料載入中...

2022/07/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/07/22

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/07/22

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/06/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

重要事件披露

8-K - Current report
2022/06/21

重要事件披露

8-K - Current report
2022/06/13

重要事件披露

8-K - Current report
2022/05/11

重要事件披露

8-K - Current report
2022/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/25

重要事件披露

8-K - Current report
2022/03/24

重要事件披露

8-K - Current report
2022/03/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/09

重要事件披露

8-K - Current report
2022/03/07

重要事件披露

8-K - Current report
2022/03/07

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans